Concepedia

Philip Parsons

PP

Statistics

Publications

6

Citations

202

H-Index

6

Active since

1984

Affiliations

Velindre Cancer Centre(Current)

University of Leeds

The Christie NHS Foundation Trust

Velindre NHS Trust

University of Oxford

Philip Parsons is an author at Velindre Cancer Centre specializing in oncology, medicine, and radiation therapy.

Publications per year

1984–2020

6

Publications

6

Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy.

Roger Lindley, A S Bulman, Philip Parsons et al. · PubMed · 1989 · 76 citations

Medicine, Oncology, Pathology +17

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS

Simon Gollins, Nicholas P. West, David Sebag‐Montefiore et al. · British Journal of Cancer · 2018 · 43 citations · Full text

Medicine, Oncology, Surgery +17

Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.

R. S. Aroney, W. C. Dermody, Paul H. Aldenderfer et al. · PubMed · 1984 · 28 citations

Medicine, Oncology, Pathology +17

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

David Sebag‐Montefiore, Richard Adams, Simon Gollins et al. · Journal of Clinical Oncology · 2020 · 22 citations

Medicine, Oncology, Radiation Oncology +17

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)

Victoria Y. Strauss, Rachel Shaw, Pradeep S. Virdee et al. · BMC Cancer · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 6